Ryan Watts, Denali CEO
Denali unveil proof-of-concept data for brain delivery tech in rare disease, with eyes on much bigger indications
Nearly a year after unveiling their brain delivery technology in Science Translational Medicine, Denali has delivered promising new results from a trial that used …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.